BRIEF published on 10/15/2024 at 19:10, 1 month 5 days ago Telekom Austria: A1 Group Announces Q3 and 1-9M 2024 Results Revenue Growth EBITDA Improvement Telekom Austria Sustainability Rating Q3 2024 Results
PRESS RELEASE published on 10/15/2024 at 19:05, 1 month 5 days ago Telekom Austria: A1 Group announces results for Q3 and 1-9M 2024. Telekom Austria's A1 Group reports Q3 & 1-9M 2024 results with revenue and EBITDA growth, improved margin, lower CAPEX, and strong ESG rating Revenue Growth Q3 Results A1 Group Telekom Austria 1-9M 2024
BRIEF published on 06/27/2024 at 17:28, 4 months 23 days ago Telekom Austria AG: Summary of Resolutions from the Annual General Meeting Annual General Meeting Auditor Dividend Supervisory Board Telekom Austria AG
PRESS RELEASE published on 06/27/2024 at 17:23, 4 months 23 days ago Telekom Austria AG: Summary of the resolutions of the Annual General Meeting Telekom Austria AG announces key resolutions at the Annual General Meeting including dividend distribution and board elections Annual General Meeting Dividend Distribution Resolutions Board Elections Telekom Austria AG
BRIEF published on 04/16/2024 at 19:10, 7 months 4 days ago Telekom Austria's A1 Group Reports Q1 2024 Results Revenue Growth EBITDA Increase Q1 2024 Financial Results Telekom Austria A1 Group Results
PRESS RELEASE published on 04/16/2024 at 19:05, 7 months 4 days ago A1 Group: Results Q1 2024 Telekom Austria's A1 Group reports Q1 2024 results with 0.7% total revenue growth and 4.2% EBITDA increase. Future outlook includes revenue and EBITDA growth projections for 2024-2026 Revenue Growth A1 Group EBITDA Increase Q1 2024 Results Telekom Austria
PRESS RELEASE published on 02/13/2024 at 19:00, 9 months 7 days ago A1 Group: Results for Q4 2023 and for the full year 2023 A1 Group announces Q4 2023 and full year 2023 results with revenue growth, EBITDA increase, credit rating upgrade, and dividend proposal. Visit https://a1.group/investor-relations/ for more info Revenue Growth Dividend Proposal Q4 2023 Results A1 Group EBITDA Increase
PRESS RELEASE published on 10/17/2023 at 19:02, 1 year 1 month ago Telekom Austria AG: Results for Q3 2023 and Q1-Q3 2023.
PRESS RELEASE published on 09/21/2023 at 18:34, 1 year 1 month ago EQS-Adhoc: Telekom Austria AG: Reference price of EuroTeleSites shares set at EUR 4.95 per share
PRESS RELEASE published on 09/12/2023 at 12:09, 1 year 2 months ago Telekom Austria AG: Corporate News: Listing of Telekom Austria AG's tower business on the Official Market of the Vienna Stock Exchange expected to commence on September 22, 2023.
Published on 11/21/2024 at 13:00, 37 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 37 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 37 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 37 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 1 hour 2 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 22 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 52 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
